Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...

Eli Lilly and Novo Nordisk already make popular GLP-1s in the Triangle. A Swiss drugmaker says its future Wake County site ...

Jameela Jamil is clarifying her previous statement regarding Serena Williams and GLP-1s. Here's what she said.

After years of training at the highest level, Serena Williams choosing a GLP-1 isn’t taking the “easy” way out—it’s doing what’s best for her body now.

About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...

Celebrities have access to doctors that most others don’t,” says Jameela Jamil, who flagged the risks of GLP-1s like those ...

The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.

Tennis star Serena Williams recently attributed her dramatic weight loss to GLP-1 medication but according to “The Good Place ...

A new study led by the Kinsey Institute analyzed how GLP-1 weight-loss drugs are changing people’s dating lives.

The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...

Serena Williams' weight loss was aided GLP-1 medication for weight loss, losing 31 pounds. The tennis legend speaks on ...

The company raised its full-year revenue guidance from a range of $58 billion to $61 billion to a range of $60 billion to $62 ...